the reality with mvh is that it is still going to take some time for deals and revenue to flow:
BUT ....
they have done a lot of groundwork in india and china they have options for raising cash without dilution the business plan for recurring revenue is on track management is now fully focused on shareholders interests the cochlear sims are top notch and fill a gap in the market the stock is not anywhere near fully valued worldwide govt health spends are increasing talk of diversification that will provide instant cash flow strong hands now hold/management have not sold one share biostocks due for some sector rotation roadshows due to start in coming 3-6 months
etc etc
MVH Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held